113 related articles for article (PubMed ID: 22582508)
21. Anti-52 kDa Ro(SSA) autoantibodies in different autoimmune diseases preferentially recognize epitopes on the central region of the antigen.
Dorner T; Feist E; Wagenmann A; Kato T; Yamamoto K; Nishioka K; Burmester GR; Hiepe F
J Rheumatol; 1996 Mar; 23(3):462-8. PubMed ID: 8832984
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of diagnostic tests for antinuclear antibodies in rheumatological practice.
Ulvestad E; Kanestrøm A; Madland TM; Thomassen E; Haga HJ; Vollset SE
Scand J Immunol; 2000 Sep; 52(3):309-15. PubMed ID: 10972909
[TBL] [Abstract][Full Text] [Related]
23. Relevance of the inner mitochondrial membrane enzyme F1F0-ATPase as an autoantigen in autoimmune liver disorders.
Preuss B; Berg C; Dengjel J; Stevanovic S; Klein R
Liver Int; 2012 Feb; 32(2):249-57. PubMed ID: 22098431
[TBL] [Abstract][Full Text] [Related]
24. Anti-multiple nuclear dots (anti-MND) and anti-SP100 antibodies in hepatic and rheumatological disorders.
Muratori P; Muratori L; Cassani F; Terlizzi P; Lenzi M; Rodrigo L; Bianchi FB
Clin Exp Immunol; 2002 Jan; 127(1):172-5. PubMed ID: 11882049
[TBL] [Abstract][Full Text] [Related]
25. Prevalence, kinetics, and therapeutic modulation of autoantibodies against Sp100 and promyelocytic leukemia protein in a large cohort of patients with primary biliary cirrhosis.
Züchner D; Sternsdorf T; Szostecki C; Heathcote EJ; Cauch-Dudek K; Will H
Hepatology; 1997 Nov; 26(5):1123-30. PubMed ID: 9362351
[TBL] [Abstract][Full Text] [Related]
26. Multiple nuclear dots and rim-like/membranous IgG isotypes in primary biliary cirrhosis.
Muratori P; Granito A; Ferri S; Pappas G; Volta U; Menichella R; Bianchi FB; Lenzi M; Muratori L
Autoimmunity; 2009 Mar; 42(3):224-7. PubMed ID: 19301204
[TBL] [Abstract][Full Text] [Related]
27. PBC screen: an IgG/IgA dual isotype ELISA detecting multiple mitochondrial and nuclear autoantibodies specific for primary biliary cirrhosis.
Liu H; Norman GL; Shums Z; Worman HJ; Krawitt EL; Bizzaro N; Vergani D; Bogdanos DP; Dalekos GN; Milkiewicz P; Czaja AJ; Heathcote EJ; Hirschfield GM; Tan EM; Miyachi K; Bignotto M; Battezzati PM; Lleo A; Leung PS; Podda M; Gershwin ME; Invernizzi P
J Autoimmun; 2010 Dec; 35(4):436-42. PubMed ID: 20932720
[TBL] [Abstract][Full Text] [Related]
28. Antinuclear antibodies as ancillary markers in primary biliary cirrhosis.
Granito A; Muratori P; Quarneti C; Pappas G; Cicola R; Muratori L
Expert Rev Mol Diagn; 2012 Jan; 12(1):65-74. PubMed ID: 22133120
[TBL] [Abstract][Full Text] [Related]
29. [Antinuclear antibodies in primary biliary cirrhosis].
Mzali S; Johanet C; Chrétien P; Abuaf N
Gastroenterol Clin Biol; 1989; 13(8-9):690-5. PubMed ID: 2680726
[TBL] [Abstract][Full Text] [Related]
30. High prevalence of anti-mitochondrial antibodies among patients with some well-defined connective tissue diseases.
Mouritsen S; Demant E; Permin H; Wiik A
Clin Exp Immunol; 1986 Oct; 66(1):68-76. PubMed ID: 3802575
[TBL] [Abstract][Full Text] [Related]
31. Clinical correlation of antimitochondrial antibodies.
Zuber MA; Recktenwald C
Eur J Med Res; 2003 Feb; 8(2):61-70. PubMed ID: 12626283
[TBL] [Abstract][Full Text] [Related]
32. [Patterns of anti-nuclear antibodies in patients with primary biliary cirrhosis and primary Sjögren syndrome].
You X; Liu W; Zhang X; Zhang FC
Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(3):168-70. PubMed ID: 18361813
[TBL] [Abstract][Full Text] [Related]
33. Prevalence and clinical associations of anti-Ku antibodies in systemic autoimmune diseases.
Cavazzana I; Ceribelli A; Quinzanini M; Scarsi M; Airò P; Cattaneo R; Franceschini F
Lupus; 2008 Aug; 17(8):727-32. PubMed ID: 18625650
[TBL] [Abstract][Full Text] [Related]
34. [Clinical significance of anti-centromere antibody and anti-CENP-B antibody in sera of patients with primary biliary cirrhosis].
Onozuka Y; Shibata M; Yonezawa H; Terauti K; Miyachi K; Ueno Y
Rinsho Byori; 1996 Sep; 44(9):877-82. PubMed ID: 8911074
[TBL] [Abstract][Full Text] [Related]
35. Anti-telomere antibodies in systemic lupus erythematosus (SLE): a comparison with five antinuclear antibody assays in 430 patients with SLE and other rheumatic diseases.
Salonen EM; Miettinen A; Walle TK; Koskenmies S; Kere J; Julkunen H
Ann Rheum Dis; 2004 Oct; 63(10):1250-4. PubMed ID: 15361381
[TBL] [Abstract][Full Text] [Related]
36. Value of autoantibody analysis in the differential diagnosis of chronic cholestatic liver disease.
Milkiewicz P; Buwaneswaran H; Coltescu C; Shums Z; Norman GL; Heathcote EJ
Clin Gastroenterol Hepatol; 2009 Dec; 7(12):1355-60. PubMed ID: 19631286
[TBL] [Abstract][Full Text] [Related]
37. [Significance of antinuclear anti-histone antibodies].
Ferec C; Youinou P; Le Goff P; Miossec P; Morin JF; Pennec Y; Morin PP; Le Menn G
Ann Med Interne (Paris); 1984; 135(6):427-30. PubMed ID: 6334466
[TBL] [Abstract][Full Text] [Related]
38. Prevalence of antinucleosome antibodies by enzyme-linked immunosorbent assays in patients with systemic lupus erythematosus and other autoimmune systemic diseases.
Půtová I; Dostal C; Becvar R
Ann N Y Acad Sci; 2007 Aug; 1109():275-86. PubMed ID: 17785316
[TBL] [Abstract][Full Text] [Related]
39. Clinical significance of autoantibodies directed against nuclear and cytoplasmic antigens in autoimmune liver disease.
McLean F
Br J Biomed Sci; 2013; 70(1):10-4. PubMed ID: 23617092
[TBL] [Abstract][Full Text] [Related]
40. Is prevalence of PBC underestimated in patients with systemic sclerosis?
Norman GL; Bialek A; Encabo S; Butkiewicz B; Wiechowska-Kozlowska A; Brzosko M; Shums Z; Milkiewicz P
Dig Liver Dis; 2009 Oct; 41(10):762-4. PubMed ID: 19357001
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
